Medicare Enrolled

Dr. Intazam Khan, MD

Neurology · Astoria, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2531 30TH RD, Astoria, NY 11102
7182678510
In practice since 2006 (19 years)
NPI: 1548352594 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khan

Dr. Intazam Khan is a neurology specialist in Astoria, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 345 Medicare services across 153 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khan received a total of $58,038 from 61 pharmaceutical and/or device companies across 974 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 345 Medicare services $58,038 industry payments

Medicare Practice Summary

Medicare Utilization ↗
345
Medicare services
Bottom 43% in NY for neurology
153
Unique beneficiaries
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
202 $114 $217
Complete ultrasound scan of joint
An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures.
44 $48 $112
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
40 $91 $191
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
27 $149 $258
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
20 $263 $498
Placement of skin electrodes and measurement of stimulated sites on arms and legs
This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs.
12 $349 $645
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$58,038
Total received (2018-2024)
Avg $8,291/year across 7 years
Top 10% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
974
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36,140 (62.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,089 (29.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,809 (8.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,288
2023
$11,656
2022
$5,606
2021
$11,687
2020
$1,567
2019
$3,736
2018
$20,498

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$336
ABBVIE INC.
$314
MDD US Operations, LLC
$300
SK Life Science, Inc.
$259
Teva Pharmaceuticals USA, Inc.
$247
ANI Pharmaceuticals, Inc.
$226
SCILEX PHARMACEUTICALS INC.
$205
PFIZER INC.
$183
JAZZ PHARMACEUTICALS INC.
$125
Eisai Inc.
$117
ARGENX US, INC.
$115
Neurocrine Biosciences, Inc.
$107
Alexion Pharmaceuticals, Inc.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$90
Lilly USA, LLC
$90
Otsuka America Pharmaceutical, Inc.
$70
Mallinckrodt Hospital Products Inc.
$64
Azurity Pharmaceuticals, Inc.
$64
CATALYST PHARMACEUTICALS, INC.
$57
Lundbeck LLC
$42
TG Therapeutics, Inc.
$39
Amneal Pharmaceuticals LLC
$38
AstraZeneca Pharmaceuticals LP
$27
Amgen Inc.
$22
Celgene Corporation
$18
Biogen, Inc.
$18
Sumitomo Pharma America, Inc.
$15
Top 3 companies account for 28.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$11,758
GENZYME CORPORATION
$8,462
AbbVie Inc.
$7,423
Genentech USA, Inc.
$5,097
Mallinckrodt LLC
$4,345
PFIZER INC.
$3,054
Teva Pharmaceuticals USA, Inc.
$1,943
Allergan, Inc.
$1,779
LivaNova USA, Inc.
$1,564
UCB, Inc.
$1,469
Biogen, Inc.
$1,327
Novartis Pharmaceuticals Corporation
$818
Neurocrine Biosciences, Inc.
$601
ANI Pharmaceuticals, Inc.
$578
SK Life Science, Inc.
$572
Lundbeck LLC
$481
Scilex Pharmaceuticals Inc.
$465
Sunovion Pharmaceuticals Inc.
$381
SCILEX PHARMACEUTICALS INC.
$345
MDD US Operations, LLC
$340
Mallinckrodt Hospital Products Inc.
$320
Amgen Inc.
$283
Eisai Inc.
$269
Vertical Pharmaceuticals, LLC
$263
Neurelis, Inc.
$232
Adamas Pharmaceuticals, Inc.
$229
Lilly USA, LLC
$221
Celgene Corporation
$208
Otsuka America Pharmaceutical, Inc.
$201
TG THERAPEUTICS, INC.
$197
Sumitomo Pharma America, Inc.
$176
Alexion Pharmaceuticals, Inc.
$173
Mallinckrodt Enterprises LLC
$169
JAZZ PHARMACEUTICALS INC.
$168
Avanir Pharmaceuticals, Inc.
$166
Janssen Pharmaceuticals, Inc
$162
EMD Serono, Inc.
$162
ARGENX US, INC.
$162
Azurity Pharmaceuticals, Inc.
$156
Amneal Pharmaceuticals LLC
$146
E.R. Squibb & Sons, L.L.C.
$137
Takeda Pharmaceuticals U.S.A., Inc.
$129
Supernus Pharmaceuticals, Inc.
$98
EISAI INC.
$88
CATALYST PHARMACEUTICALS, INC.
$76
Exeltis, USA Inc.
$72
ARBOR PHARMACEUTICALS, INC.
$71
Arbor Pharmaceuticals, Inc.
$68
Horizon Therapeutics plc
$64
Biohaven Pharmaceuticals, Inc.
$49
Neuronetics, Inc.
$49
TG Therapeutics, Inc.
$39
Boston Scientific Corporation
$34
Grifols USA, LLC
$33
Harmony Biosciences LLC
$29
AstraZeneca Pharmaceuticals LP
$27
Biohaven Pharmaceutical Holding Company Ltd.
$25
OWP Pharmaceuticals, Inc.
$25
Abbott Laboratories
$22
Acorda Therapeutics, Inc
$21
Upsher-Smith Laboratories LLC
$18
Top 3 companies account for 47.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BRIUMVI · Briviact · CREXONT · EMGALITY · EPIDIOLEX · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD LIQUID · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HORIZANT · HYQVIA · Horizant · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAYZENT · Mavenclad · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NUEDEXTA · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · OSMOLEX ER · Ocrevus · Ongentys · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RYTARY · SOLIRIS · Soliris · Subvenite · TECFIDERA · TOPIRAMATE Extended Release Capsules · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XCOPRI · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for neurology in NY.

Looking for a neurology specialist in Astoria?
Compare neurologists in the Astoria area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
1,273
Per 100K population
54.6
County median income
$84,961
Nearest hospital
LENOX HILL HOSPITAL
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khan is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 10% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khan performed 202 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $58,038 from 61 companies across 974 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other neurologists in Astoria?
Dr. Khan's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →